|
AU2019291061A1
|
|
Compositions for treating and/or preventing protein-aggregation diseases
|
|
ES2798182A1
|
|
System for neurostimulation
|
|
ES2684431A1
|
|
Device direct valuation device
|
|
ES2673673A1
|
|
Method for the treatment of wastewater based on photoxidation by ultraviolet light
|
|
ES2647134A1
|
|
Method of molecular determination of bird sex by isothermal amplification by loop
|
|
ES2547932A1
|
|
Post-synthesis procedure for surface modification of superparamagnetic iron oxide nanoparticles
|
|
ES2536117A1
|
|
Stabilizing compounds of apoptotic cells
|
|
ES2525365A1
|
|
Materials operated with nad * or nadp * and its application in biosensors and other devices
|
|
ES2514265A1
|
|
Biocides nanoestructures
|
|
ES2514140A1
|
|
Use of the STX64 steroid sulfatase inhibitor for the treatment of aging
|
|
ES2482265A1
|
|
Control system of untripulated aircraft of rotary wing for vertical landing on mobile surfaces through pre-feeding of forces in the control system
|
|
ES2453202A1
|
|
Operating conditioning box and instrumental learning for rabbits
|
|
EP2735265A1
|
|
Device for animal experimentation in neuroscience research
|
|
ES2438617A1
|
|
Method for screening and / or evaluation of the efficacy of medications for the treatment of mitochondrial diseases and MELAS syndrome
|
|
ES2407055A1
|
|
EMPLOYMENT OF ANTI-BETA-LACTOGLOBULIN ANTIBODIES IN THE DIAGNOSIS AND FOLLOW-UP OF CELIAC DISEASE
|
|
EP2641962A1
|
|
Pichia kluyveri strain and uses thereof
|
|
ES2389186A1
|
|
Procedure for obtaining metallic nanoparticles functioned with fluorescent organic molecules
|
|
ES2383973A1
|
|
METHOD OF ENRICHMENT OF NEMATODES WITH FATTY ACIDS.
|
|
ES2399668A1
|
|
CULTURE OF MARINE BACTERIA IN MILK SERUM
|
|
ES2383076A1
|
|
HETEROLOGICAL EXPRESSION SYSTEMS FOR THE FUNCTIONAL ANALYSIS OF METAGENOMIC LIBRARIES.
|
